Ugur Sahin, AP Images
Covid-19 manufacturing roundup: BioNTech announces plans to produce mRNA vaccines in Africa; AstraZeneca deliveries from Thailand delayed
BioNTech, Pfizer’s partner on its Covid-19 vaccine, will look to establish mRNA vaccine production facilities in Africa, the Financial Times reported Wednesday.
The move is a part of a larger push to tackle diseases beyond Covid-19, and as the EU looks to up its manufacturing capacity on the continent. Right now, Africa imports over 99% of the vaccines it uses, the FT reports. The plan was outlined in a call between CEO Ugur Sahin and European Commission President Ursula von der Leyen before the G7 summit.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
